Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1993 Oct;10(10):1507-15.
doi: 10.1023/a:1018939728993.

Physicochemical characterization of high- and low-melting phenylephrine oxazolidines

Affiliations

Physicochemical characterization of high- and low-melting phenylephrine oxazolidines

Y Qiu et al. Pharm Res. 1993 Oct.

Abstract

Phenylephrine oxazolidine is a new prodrug of phenylephrine developed for improving ocular absorption and reducing systemic side effects. In the present study, high- and low-melting phenylephrine oxazolidines (HMP and LMP) were characterized in terms of their stereochemistry and crystal properties. It was found that the molecular configuration of the prodrug in the crystals of either HMP or LMP is identical (5R/2R). The two crystals were shown to have the same IR spectra and X-ray diffraction patterns but different crystal habits, thermal properties, solubilities and intrinsic dissolution rates. Single crystal X-ray structure analysis indicates that crystals of both HMP and LMP are orthorhombic and belong to the P2(1)2(1)2(1) space group with four molecules in a unit cell (a = 20.697 A, b = 7.065 A, and c = 9.304 A). The molecules in the crystal are held together by an intermolecular hydrogen bonding interaction between N(3) and O(13). The different physical properties observed for LMP result from crystal imperfections caused by the presence of trace amounts (often at levels < 0.5%) of an unidentified, structurally related synthetic impurity which can be dispersed in the prodrug. It was observed that both HMP and LMP can sustain thermal and mechanical treatment in the solid state. However, LMP was partially converted to HMP when suspended in certain solvents.

PubMed Disclaimer

Similar articles

Cited by

  • Prodrug strategies in ocular drug delivery.
    Barot M, Bagui M, Gokulgandhi MR, Mitra AK. Barot M, et al. Med Chem. 2012 Jul;8(4):753-68. doi: 10.2174/157340612801216283. Med Chem. 2012. PMID: 22530907 Free PMC article. Review.

References

    1. Pharm Res. 1990 May;7(5):476-83 - PubMed
    1. J Ocul Pharmacol. 1987 Winter;3(4):333-40 - PubMed
    1. Biopharm Drug Dispos. 1986 Sep-Oct;7(5):453-62 - PubMed
    1. Ophthalmology. 1991 Feb;98(2):222-6 - PubMed
    1. J Pharm Sci. 1979 Aug;68(8):1005-9 - PubMed

LinkOut - more resources